Total Payments
$699.50
2024 Payments
$115.01
Companies
17
Transactions
36
Medicare Patients
10,029
Medicare Billing
$451,746
Payment Breakdown by Category
Food & Beverage$685.61 (98.0%)
Education$13.89 (2.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $685.61 | 35 | 98.0% |
| Education | $13.89 | 1 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $163.83 | 8 | $0 (2023) |
| GlaxoSmithKline, LLC. | $118.16 | 5 | $0 (2024) |
| ABBVIE INC. | $73.06 | 3 | $0 (2023) |
| PFIZER INC. | $73.01 | 4 | $0 (2024) |
| Novo Nordisk Inc | $40.40 | 2 | $0 (2022) |
| Astellas Pharma US Inc | $36.92 | 2 | $0 (2021) |
| Bayer HealthCare Pharmaceuticals Inc. | $29.70 | 2 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $24.06 | 1 | $0 (2019) |
| ITI, Inc. | $20.33 | 1 | $0 (2022) |
| Takeda Pharmaceuticals America, Inc. | $19.00 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $115.01 | 5 | GlaxoSmithKline, LLC. ($76.40) |
| 2023 | $128.50 | 6 | Novartis Pharmaceuticals Corporation ($65.89) |
| 2022 | $151.47 | 8 | Novartis Pharmaceuticals Corporation ($61.76) |
| 2021 | $168.99 | 9 | Astellas Pharma US Inc ($36.92) |
| 2019 | $42.94 | 2 | SANOFI-AVENTIS U.S. LLC ($24.06) |
| 2018 | $45.62 | 3 | Gilead Sciences, Inc. ($17.70) |
| 2017 | $46.97 | 3 | Takeda Pharmaceuticals America, Inc. ($19.00) |
All Payment Transactions
36 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $25.79 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: RESPIRATORY | ||||||
| 09/05/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $34.20 | General |
| Category: RESPIRATORY | ||||||
| 01/31/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/01/2023 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $16.51 | General |
| 08/15/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/20/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/27/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $31.58 | General |
| Category: NEUROSCIENCE | ||||||
| 01/09/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/16/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Cardio-renal | ||||||
| 08/18/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/13/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Diabetes | ||||||
| 06/02/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: PSYCHIATRY | ||||||
| 05/18/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/17/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/24/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: RESPIRATORY | ||||||
| 01/27/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Cardio-renal | ||||||
| 12/08/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: UROLOGY | ||||||
| 10/25/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/21/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Diabetes | ||||||
| 07/03/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: UROLOGY | ||||||
| 06/16/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/10/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 1,887 | 2,803 | $425,860 | $88,812 |
| 2022 | 36 | 2,287 | 3,999 | $466,453 | $91,369 |
| 2021 | 43 | 2,809 | 4,895 | $486,979 | $128,828 |
| 2020 | 39 | 3,046 | 5,624 | $442,345 | $142,736 |
Total Patients
10,029
Total Services
17,321
Medicare Billing
$451,746
Procedure Codes
150
All Medicare Procedures & Services
150 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 140 | 286 | $80,080 | $16,949 | 21.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 56 | 95 | $38,000 | $8,587 | 22.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 76 | 78 | $31,200 | $6,964 | 22.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 21 | 38 | $34,200 | $6,233 | 18.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 20 | 20 | $5,800 | $5,609 | 96.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 36 | 138 | $13,800 | $5,382 | 39.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 37 | 38 | $26,600 | $4,456 | 16.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 94 | 94 | $37,600 | $4,215 | 11.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 76 | 95 | $23,750 | $3,574 | 15.0% |
| 83021 | Hemoglobin analysis and measurement, chromatography | Office | 2023 | 141 | 199 | $15,920 | $3,522 | 22.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 60 | 60 | $15,600 | $3,441 | 22.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 68 | 76 | $30,400 | $3,289 | 10.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 143 | 197 | $14,775 | $2,585 | 17.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 35 | 36 | $5,400 | $2,487 | 46.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 157 | 315 | $1,890 | $1,839 | 97.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 22 | 22 | $11,440 | $1,726 | 15.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 27 | 41 | $6,150 | $1,423 | 23.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 107 | 135 | $10,125 | $1,397 | 13.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 61 | 82 | $5,740 | $1,350 | 23.5% |
| 80069 | Kidney function blood test panel | Office | 2023 | 95 | 109 | $2,725 | $927.59 | 34.0% |
| 85610 | Blood test, clotting time | Office | 2023 | 36 | 145 | $2,900 | $609.00 | 21.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 54 | 79 | $2,765 | $601.19 | 21.7% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 16 | 65 | $1,625 | $459.00 | 28.2% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 75 | 83 | $1,230 | $236.28 | 19.2% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 41 | 62 | $2,170 | $198.11 | 9.1% |
About Dr. Wendy Haack, D.O
Dr. Wendy Haack, D.O is a Internal Medicine healthcare provider based in Coos Bay, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2007. The National Provider Identifier (NPI) number assigned to this provider is 1518164250.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wendy Haack, D.O has received a total of $699.50 in payments from pharmaceutical and medical device companies, with $115.01 received in 2024. These payments were reported across 36 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($685.61).
As a Medicare-enrolled provider, Haack has provided services to 10,029 Medicare beneficiaries, totaling 17,321 services with total Medicare billing of $451,746. Data is available for 4 years (2020–2023), covering 150 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Coos Bay, OR
- Active Since 06/27/2007
- Last Updated 11/02/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1518164250
Products in Payments
- ENTRESTO (Drug) $121.56
- TRELEGY ELLIPTA (Drug) $57.08
- ELIQUIS (Drug) $56.49
- LEQVIO (Drug) $42.27
- AREXVY (Drug) $42.20
- VRAYLAR (Drug) $41.48
- MYRBETRIQ (Drug) $36.92
- UBRELVY (Drug) $31.58
- Kerendia (Drug) $29.70
- SOLIQUA 100/33 (Drug) $24.06
- RYBELSUS (Drug) $23.60
- CAPLYTA (Drug) $20.33
- Trintellix (Drug) $19.00
- BEXSERO (Biological) $18.88
- Rybelsus (Drug) $16.80
- TOVIAZ (Drug) $16.52
- Carnation Ambulatory Monitor (Device) $15.00
- Prolia (Biological) $14.08
- STIOLTO (Drug) $13.89
- Livalo (Drug) $12.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Coos Bay
Stacy Newman, Md, MD
Internal Medicine — Payments: $3,909
Internal Medicine $3,909
Carol Frank, Md, MD
Internal Medicine — Payments: $2,757
Internal Medicine $2,757
Dr. Joseph El Youssef, M.d, M.D
Internal Medicine — Payments: $1,892
Internal Medicine $1,892
Dr. Satish Bankuru, M.d, M.D
Internal Medicine — Payments: $1,739
Internal Medicine $1,739
Dr. Basil Pittenger, Md, MD
Internal Medicine — Payments: $744.47
Internal Medicine $744.47
Bhavani Peddagovindu, Md, MD
Internal Medicine — Payments: $674.59
Internal Medicine $674.59